IMS Health Plans IPO

Pharma research giant IMS Health Holdings has filed a registration with the US Securities and Exchange Commission (SEC) for an Initial Public Offering (IPO) on the New York Stock Exchange.

Rumours about the likelihood of an IPO have been circulating for some time. An initial maximum offering price of $100m is said to be a 'placeholder' until the price and number of shares are settled. Some analysts suggested the amount raised would be up to $1bn.

IMS was taken private in March 2010 by investment firms TPG Capital and the Canada Pension Plan Investment Board (CPPIB), who paid $5.2bn. Since then it has appointed a new CEO, Ari Bousbib (pictured), who replaced David Carlucci in August 2010; and made a number of acquisitions including that of rival data provider SDI in October 2011. Last year, it bought Swedish life sciences advisory and analytics firm Pygargus, the assets of Toronto-based Diversinet, SaaS firm Incential Software, US marketing technology provider 360 Vantage, social media analytics firm Semantelli and Seattle-based technology firm Appature.

IMS says it will use the proceeds of the IPO to repay long-term debt and for 'general corporate purposes'. The company reports revenue up 4 percent to $1.87bn in the nine months to September 30th 2013.

Web site: www.imshealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• IMS Health Inc
• All news